Use of beta-blocking agents with group therapy in a smoking withdrawal clinic.
A controlled trial was carried out into the relative efficacy of two beta-blocking agents (oxprenolol and metoprolol) as adjuncts to group therapy in a smoking withdrawal clinic. There was no evidence to indicate that these were of specific value in assisting smoking withdrawal.
D000328:Adult; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D010096:Oxprenolol / Q000627:therapeutic use*; D011615:Psychotherapy, Group; D012907:Smoking; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000628:therapy*
D010096:Oxprenolol; D008790:Metoprolol